ABRAHAM J AND PHYLLIS KATZ CORD BLOOD FOUND has a total of 17 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are THANKSTEM S R L, BOULIKAS PARTHENIOS and LENTIGEN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Laughlin Mary | 17 |
#2 | Do Jeong Su | 5 |
#3 | Greene-Roos Jennifer | 4 |
#4 | Van'T Hof Wouter | 3 |
#5 | Do Jeong-Su | 3 |
#6 | Zwick Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020150580A1 | Dual stem cell therapy for neurological conditions | |
WO2020102321A1 | T cells with improved mitochondrial function | |
EP3807398A1 | Isolation of mesenchymal stromal cells from umbilical cord blood | |
CA3061508A1 | Enriched cellular compositions and therapeutic use | |
CA3053129A1 | Methods of treating hiv infection with allogeneic ccr5 null umbilical cord blood cells | |
US2019376032A1 | T Cells Derived from Umbilical Cord Blood |